Clinical trial
Randomized Controlled Trial of Lorcaserin for Cannabis Use Disorder
NCT03637842 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Lorcaserin for Cannabis Use Disorder
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- August 1, 2019
- Completion date
- February 29, 2020
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cannabis use disorder